ASyO5-biotinylated | Mouse anti-human alpha-synuclein | oligomer-specific

AS13 2718B | Clonality: monoclonal | Host: Mouse | Reactivity: Human

Product Information

Immunogen Synthetic peptide derived from human alpha-synuclein Gly111-Tyr125

Host Mouse

Clonality Monoclonal

Subclass/isotype IgG1

Purity Immunogen affinity purified serum in PBS pH 7.4.

Format Lyophilized

Quantity 50 µg

Reconstitution For reconstitution add 50 µl of sterile water

Storage Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube.

Tested applications ELISA (ELISA)

Recommended dilution 2-4 µg/ml (ELISA)

Expected | apparent MW

14 kDa

Reactivity

Confirmed reactivity Human

Application examples

Additional information

Additional information Antibody is biotinylated

Preparation of α-synuclein oligomers and fibrils is described here.

Background

Alpha-synuclein is normally an unstructured soluble protein that can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy-bodies, and multiple system atrophy. In analogy to many other amyloid associated disorders, alpha-synuclein may also form oligomeric assemblies. These small and soluble forms have been suggested to exert a stronger tissue damaging effect as compared to the monomeric and fibrillar counterpart. Using a recently developed technique a monoclonal oligomer-specific antibody has been designed.

Product citations

Selected references Brännström et al. (2014). A Generic Method for Design of Oligomer-Specific Antibodies. PLoS ONE. DOI: 10.1371/journal.pone.0090857.

Related products: ASyO5-biotinylated | Mouse anti-human alpha-synuclein | oligomer-specific

ASyM | Mouse anti-human alpha synuclein N-terminal (clone number 4,2)

AS13 2719 | Clonality: monoclonal | Host: Mouse | Reactivity: H...

618 €

ASyM-biotinylated | Mouse anti-human alpha synuclein N-terminal

AS13 2719B | Clonality: monoclonal | Host: Mouse | Reactivity: ...

618 €

ASyO2-biotinylated | Mouse anti-human alpha-synuclein | oligomer-specific

AS13 2717B | Clonality: monoclonal | Host: Mouse | Reactivity: ...

618 €

Rabbit anti-Mouse IgG (H&L), HRP conjugated

AS09 627 | Clonality: Polyclonal | Host: Rabbit | Reactivity: Mouse IgG (H&L...

206 €

Picture (footer):
All references:	Brännström et al. (2014). A Generic Method for Design of Oligomer-Specific Antibodies. PLoS ONE. DOI: 10.1371/journal.pone.0090857.
background:	Alpha-synuclein is normally an unstructured soluble protein that can aggregate to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy-bodies, and multiple system atrophy. In analogy to many other amyloid associated disorders, alpha-synuclein may also form oligomeric assemblies. These small and soluble forms have been suggested to exert a stronger tissue damaging effect as compared to the monomeric and fibrillar counterpart. Using a recently developed technique a monoclonal oligomer-specific antibody has been designed.
calculated \| apparent molecular mass [kDa]:	14 kDa
Clonality:	Monoclonal
Format:	Lyophilized
Host:	Mouse
immunogen:	Synthetic peptide derived from human alpha-synuclein Gly111-Tyr125
Purity:	Immunogen affinity purified serum in PBS pH 7.4.
Quantity:	50 µg
recommended dilution:	2-4 µg/ml (ELISA)
Reconstitution:	For reconstitution add 50 µl of sterile water
storage:	Store lyophilized/reconstituted at -20°C; once reconstituted make aliquots to avoid repeated freeze-thaw cycles. Please remember to spin the tubes briefly prior to opening them to avoid any losses that might occur from material adhering to the cap or sides of the tube.
Sub class:	IgG1
tested applications:	ELISA (ELISA)
Confirmed reactivity:	Human
additional information:	Antibody is biotinylated
additional information (application):	Preparation of α-synuclein oligomers and fibrils is described here.